Skip to content

Study · Animal study (in vivo) · rat · 2017

10 results

α-Estrogen and Progesterone Receptors Modulate Kisspeptin Effects on Prolactin: Role in Estradiol-Induced Prolactin Surge in Female Rats.

Aquino NSS, Araujo-Lopes R, Henriques PC, Lopes FEF, Gusmao DO, Coimbra CC, Franci CR, Reis AM, Reis AM, Szawka RE

Endocrinology1 Jun 2017Cited by 26 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study10

8 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with estradiol, intracerebroventricular Kp-10 increased prolactin release.

    In plain wordsIn rats, Kp-10 given into the brain increased prolactin release when estradiol was present.

    Outcome
    IncreaseProlactin release in estradiol-treated OVX rats
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Kp-10 increased PRL release and decreased 3,4-dihydroxyphenylacetic acid levels in the median eminence (ME) of OVX rats treated with estradiol (OVX+E)
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with estradiol, intracerebroventricular Kp-10 decreased 3,4-dihydroxyphenylacetic acid levels in the median eminence.

    In plain wordsIn rats given estradiol, Kp-10 lowered a dopamine breakdown product in a brain region.

    Outcome
    DecreaseDOPAC level in median eminence
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Kp-10 increased PRL release and decreased 3,4-dihydroxyphenylacetic acid levels in the median eminence (ME) of OVX rats treated with estradiol (OVX+E)
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats without estradiol, Kp-10 did not increase prolactin or lower DOPAC.

    In plain wordsIn rats without estradiol, Kp-10 had none of the effects on prolactin seen with estradiol.

    Outcome
    No significant changeKp-10 effects in OVX rats without estradiol
    Study

    ratn: not reported in source

    Comparator
    OVX+E rats
    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Whereas these effects of Kp-10 were absent in OVX rats
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.
  4. 04AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with the ERα agonist propylpyrazole triol, the effects of Kp-10 on prolactin and DOPAC were replicated.

    In plain wordsIn rats given an estrogen receptor alpha agonist, Kp-10 had the same effects on prolactin release as with estradiol.

    Outcome
    IncreaseKp-10 effects with ERα agonist PPT
    Study

    ratn: not reported in source

    Comparator
    OVX rats
    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    they were replicated in OVX rats treated with selective agonist of estrogen receptor (ER)α, propylpyrazole triol, but not of ERβ, diarylpropionitrile.
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.
  5. 05AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with the ERβ agonist diarylpropionitrile, the effects of Kp-10 were not replicated.

    In plain wordsIn rats given an estrogen receptor beta agonist, Kp-10 did not have the effects on prolactin seen with estradiol.

    Outcome
    No significant changeKp-10 effects with ERβ agonist DPN
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    they were replicated in OVX rats treated with selective agonist of estrogen receptor (ER)α, propylpyrazole triol, but not of ERβ, diarylpropionitrile.
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.
  6. 06AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with estradiol and progesterone, the Kp-10-induced prolactin increase was two times higher than in rats given estradiol alone.

    In plain wordsIn rats, adding progesterone to estradiol doubled the prolactin increase caused by Kp-10.

    Outcome
    IncreaseKp-10-induced prolactin increase with progesterone
    Study

    ratn: not reported in source

    Comparator
    OVX+E rats
    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Furthermore, the Kp-10-induced increase in PRL was two times higher in OVX+E rats also treated with progesterone (OVX+EP)
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.
  7. 07AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with estradiol and progesterone, Kp-10 was associated with reduced expression of tyrosine hydroxylase and Ser40-phosphorylated tyrosine hydroxylase in the median eminence.

    In plain wordsIn rats given estradiol and progesterone, Kp-10 went with lower levels of a dopamine-making enzyme in a brain region.

    Outcome
    DecreaseTyrosine hydroxylase expression in median eminence
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Furthermore, the Kp-10-induced increase in PRL was two times higher in OVX+E rats also treated with progesterone (OVX+EP), which was associated with a reduced expression of both tyrosine hydroxylase (TH) and Ser40-phosphorylated TH in the ME.
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.
  8. 08AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with estradiol and progesterone, Kp-10 reduced dopamine levels in the median eminence.

    In plain wordsIn rats given estradiol and progesterone, Kp-10 lowered dopamine levels in a brain region.

    Outcome
    DecreaseDopamine level in median eminence of OVX+EP rats
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Kp-10 also reduced dopamine levels in the ME of OVX+EP rats
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.

Studies that did not test the peptide alone2

In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Kisspeptin-10.

  1. 09AnimalNot a test of Kisspeptin-10 aloneAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with estradiol, tamoxifen prevented the Kp-10-induced prolactin increase and DOPAC decrease.

    In plain wordsIn rats, tamoxifen stopped the effects of Kp-10 on prolactin release and a dopamine breakdown product.

    Outcome
    DecreaseKp-10 effect on prolactin with tamoxifen
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    which was prevented by tamoxifen.
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

  2. 10AnimalNot a test of Kisspeptin-10 aloneAnimal study (in vivo)Mechanism

    In ovariectomized rats treated with estradiol and progesterone, the progesterone receptor antagonist RU486 blocked the Kp-10-induced dopamine reduction.

    In plain wordsIn rats, a progesterone receptor blocker stopped Kp-10 from lowering dopamine in a brain region.

    Outcome
    IncreaseKp-10 dopamine reduction with RU486
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    an effect blocked by the progesterone receptor (PR) antagonist RU486.
    1 context sentence
    Summary · context
    Intracerebroventricular injections of Kp-10 or Kp-234 were performed in ovariectomized (OVX) rats under different hormonal treatments.

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.